A 35-year-old woman with established schizophrenia on risperidone develops significant weight gain (8 kg over 3 months) and elevated fasting glucose (120 mg/dL). She remains symptomatically stable. Which antipsychotic is the best alternative to minimize metabolic side effects while maintaining efficacy?